RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a Phase I study to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in adult patients with recurrent glioblastoma.
Epistemonikos ID: 36609572501bfba827603fa23ce7f6578f0ea3a5
First added on: May 16, 2024